Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Typesort ascending Project # RFA # PI/Project Leader Institution Title Status
2010 R33 RFA-CA-09-007 ROBINSON, JOSEPH PAUL PURDUE UNIVERSITY SPECIFIC DETECTION OF CERVICAL CANCERS USING CYTOMETRY-BASED MOLECULAR DIAGNOSTIC Complete
2010 R33 RFA-CA-09-007 CLAFFEY, KEVIN P. UNIVERSITY OF CONNECTICUT SCH OF MED/DNT DISCOVERY PLATFORM FOR CANCER ANTIGENS Complete
2017 R33 RFA-CA-16-002 WALTER, MATTHEW J WASHINGTON UNIVERSITY TARGETED SINGLE-MOLECULE SEQUENCING ASSAY INCORPORATING MOLECULAR BARCODES NCE
2021 R33 CA20-018 WEI, WEI INSTITUTE FOR SYSTEMS BIOLOGY Liquid biopsy-based toolkits for neoantigen and cognate TCR discovery for cancer immunotherapy Complete
2001 R33 PAR-99-100 MAJUMDAR, ARUNAVA UNIVERSITY OF CALIFORNIA BERKELEY OPTOMECHANICAL CHIPS FOR MOLECULAR PROFILING OF CANCER Complete
2013 R33 RFA-CA-13-002 BROWN, BRIAN DAVID ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI SENSOR-SEQ: A GENOME-WIDE BIOLOGICAL MEASURE OF MICRORNA ACTIVITY. Complete
2019 R33 RFA-CA-18-003 SOPER, STEVEN ALLAN UNIVERSITY OF KANSAS LAWRENCE Increased Sensitivity of Minimal Residual Disease Monitoring using Peripheral Blood in Pediatric Patients with Acute Lymphoblastic Leukemia Active
2002 R33 PAR-98-067 SHERRY, A. DEAN UNIVERSITY OF TEXAS DALLAS MRI AGENTS SENSITIVE TO BIOLOGICAL INDICATORS OF NEOPLAS Complete
2005 R33 RFA-CA-05-003 FU, XIANG-DONG UNIVERSITY OF CALIFORNIA SAN DIEGO TYPING THE TRANSCRIPTOME IN CANCER USING SPLICING ARRAY Complete
2015 R33 RFA-CA-14-004 CARON, MARC G. DUKE UNIVERSITY A CANCER RAINBOW MOUSE FOR SIMULTANEOUS ASSESSMENT OF MULTIPLE ONCOGENES Complete
2018 R33 RFA-CA-17-013 INCE, TAN A. UNIVERSITY OF MIAMI SCHOOL OF MEDICINE Live Tumor Culture Core and Tissue Specific Culture (TSC) System for Human Cancers Complete
2022 R33 CA21-004 NAEGLE, KRISTEN M UNIVERSITY OF VIRGINIA A synthetic toolkit for the recombinant production of tyrosine phosphorylated proteins and peptides Active
2017 R33 RFA-CA-16-002 PARKER, LAURIE L. UNIVERSITY OF MINNESOTA Fluorescence lifetime-based single fluorophore biosensors of post-translational modification enzyme activity NCE
2021 R33 CA20-018 CHENG, JI-XIN BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) Mapping Cancer Metabolism by Mid-infrared Photothermal Microscopy Complete
2001 R33 PAR-99-100 HERLYN, DOROTHEE M WISTAR INSTITUTE MOLECULAR CLONING OF HLA CLASS II TUMOR ANTIGENS Complete
2013 R33 RFA-CA-13-002 HSIAO, SHIH-CHIA ADHEREN, INC. THE DEVELOPMENT OF A MICROSCOPY-BASED CELL-ARRAY TOXICITY ASSAY FOR QUANTIFYING C Complete
2019 R33 RFA-CA-18-003 BREUNIG, JOSHUA JOHN CEDARS-SINAI MEDICAL CENTER GESTALT Barcoding and Single-cell Transcriptomics of Tumor Cell Evolution in Personalized Tumor Models Active
2002 R33 PAR-98-067 GIESE, ROGER WALLACE NORTHEASTERN UNIVERSITY CATION LABELING MASS SPECTROMETRY OF DNA ADDUCTS Complete
2005 R33 RFA-CA-05-003 SHIBATA, DARRYL K UNIVERSITY OF SOUTHERN CALIFORNIA HOW DO COLORECTAL CANCERS ARISE DESPITE SURVEILLANCE? Complete
2008 R33 RFA-CA-07-034 POOLE, LESLIE B. WAKE FOREST UNIVERSITY HEALTH SCIENCES PROTEOMIC PROFILING OF CANCER-RELATED REDOX SIGNALING PATHWAYS Complete
2015 R33 RFA-CA-14-004 ZHU, HENG JOHNS HOPKINS UNIVERSITY DEVELOPMENT OF A VIRION DISPLAY (VIRD) ARRAY TO PROFILE HUMAN GPCR INTERACTIONS Complete
2002 R21 PAR-01-104 HEYDUK, TOMASZ SAINT LOUIS UNIVERSITY MOLECULAR BEACONS FOR PROTEIN DETECTION Complete
2005 R21 RFA-CA-05-002 MURPHY, JOHN R. BOSTON MEDICAL CENTER NOVEL TARGETED REAGENTS THAT MODIFY ONCOGENE EXPRESSION Complete
2015 R21 RFA-CA-14-003 BAILEY, RYAN C UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN DROPLET MICROFLUIDIC PLATFORM FOR ULTRALOW INPUT EPIGENETICS Complete
2021 R21 CA20-017 FARIS, GREGORY W NUMENTUS TECHNOLOGIES INC. Decoding Individual Exosomes in Cancer Complete
1999 R21 PAR-98-067 BENSIMON, AARON PASTEUR INSTITUTE DETECTION OF GENOMIC ALTERATIONS BY MOLECULAR COMBING Complete
2007 R21 RFA-CA-07-002 SHEA, LONNIE D NORTHWESTERN UNIVERSITY TRANSFECTED CELL ARRAYS FOR CANCER RESEARCH Complete
2017 R21 RFA-CA-16-001 MOHS, AARON M. UNIVERSITY OF NEBRASKA MEDICAL CENTER Tunable Fluorescent Organic Nanoparticles for Cancer Imaging Applications NCE
2020 R21 RFA-CA-19-019 TEWARI, MUNEESH UNIVERSITY OF MICHIGAN AT ANN ARBOR Highly Specific, Amplification-free, Single-molecule Counting Of Rare Methylated Dna Cancer Biomarkers Active
2009 R21 RFA-CA-08-006 LARSON, DALE N CHARLES STARK DRAPER LABORATORY THE DEVELOPMENT OF A CHIP-SCALE NANO-CALORIMETER Complete
2013 R21 RFA-CA-12-002 WILLIAMS, JOHN CHARLES BECKMAN RESEARCH INSTITUTE/CITY OF HOPE OPTIMIZATION OF MULTIVALENT LIGANDS BY SUPER-RESOLUTION MICROSCOPY TO TREAT CANCE Complete
2000 R21 PAR-99-102 BROCK, GRAHAM J UNIVERSITY OF GLASGOW IDENTIFICATION OF M5CPG ALTERATIONS IN BREAST CARCINOMAS Complete
2022 R21 CA21-005 TANG, SINDY KAM-YAN STANFORD UNIVERSITY A micro-dissection platform for generating uniform-sized patient-derived tumor organoids (PDOs) for personalized cancer therapy Active
2002 R21 PAR-01-104 SOMMER, STEVE SEEV CITY OF HOPE/BECKMAN RESEARCH INSTITUTE PAP: A TECHNOLOGY PLATFORM Complete
2005 R21 RFA-CA-05-002 WANG, BINGHE GEORGIA STATE UNIVERSITY FLUORESCENT APTAMERS FOR GLYCOPROTEIN DETECTION Complete
2008 R21 RFA-CA-07-022 LIOTTA, LANCE ALLEN GEORGE MASON UNIVERSITY SURROGATE AND SENTINAL TECHNOLOGIES TO MONITOR STABILITY OF CANCER PHOSPHOPROTEIN Complete
2015 R21 RFA-CA-14-003 ELLINGTON, ANDREW D UNIVERSITY OF TEXAS, AUSTIN HIGH THROUGHPUT SINGLE CELL TRANSCRIPTOME ANALYSIS Complete
2021 R21 CA20-017 DIDENKO, VLADIMIR V BAYLOR COLLEGE OF MEDICINE In situ assay imaging nuclear RNA exosome activity for cancer studies Complete
1999 R21 PAR-98-067 WANG, YUE CATHOLIC UNIVERSITY OF AMERICA INTELLIGENT MAPPING OF GENE EXPRESSION PROFILES Complete
2007 R21 RFA-CA-07-002 YEE, CASSIAN FRED HUTCHINSON CAN RES CTR IDENTIFICATION OF T CELL-DEFINED ANTIGENS IN OVARIAN CANCER Complete
2010 R21 RFA-CA-09-004 WILLEY, JAMES C. UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS IMPLEMENTATION OF INNOVATIVE RNA SAMPLE QUALITY CONTROL METHODS Complete
2017 R21 RFA-CA-16-001 VAN DAM, ROBERT MICHAEL UNIVERSITY OF CALIFORNIA LOS ANGELES High-throughput radiochemistry platform for accelerated discovery and development of novel PET imaging agents for cancer Complete
2009 R21 RFA-CA-08-006 SHAPIRO, BENJAMIN UNIV OF MARYLAND, COLLEGE PARK SPATIAL, HIGH-ACCURACY, MULTIPLEXED MAPPING OF GENES IN HUMAN TISSUE SECTIONS Complete
2013 R21 RFA-CA-12-002 SOPER, STEVEN ALLAN UNIV OF NORTH CAROLINA CHAPEL HILL ACUTE MYELOID LEUKEMIA: MRD ANALYSIS USING MODULAR UFLUIDICS AND UFLOW CYTOMETRY Complete
2019 R21 RFA-CA-18-004 SINGAMANENI, SRIKANTH WASHINGTON UNIVERSITY METAL-ORGANIC FRAMEWORK AS PROTECTIVE COATING FOR CANCER BIOSPECIMEN PRESERVATION Active
2000 R21 PAR-99-102 SMITH, RICHARD D BATTELLE PACIFIC NORTHWEST LABORATORIES HIGH THROUGHPUT FTICR FOR MOLECULAR ANALYSIS OF CANCER Complete
2022 R21 CA21-003 KNOWLES, DAVID ARTHUR NEW YORK GENOME CENTER A CRISPR/Cas13 approach for identifying individual transcript isoform function in cancer Active
2002 R21 PAR-01-104 LARSON, DALE N HARVARD UNIVERSITY (MEDICAL SCHOOL) PROTEIN LOCALIZATION: MULTI-APERTURE NEAR-FIELD OPTICS Complete
2005 R21 RFA-CA-05-002 GUDKOV, ANDREI V CLEVELAND CLINIC LERNER COL/MED-CWRU ISSA: NOVEL FUNCTIONAL APPROACH TO CANCER-RELATED GENES Complete
2008 R21 RFA-CA-07-033 LANDEGREN, ULF DAG UPPSALA UNIVERSITY DIAGNOSTIC ANALYSES OF ENDOGENOUS PROTEIN INTERACTIONS Complete

Pages